OUR VISION:  A world in which every child with Progeria is cured

OUR MISSION: To discover treatments and the cure for Progeria
and its aging-related disorders, including heart disease.

Get Involved

zach superman small

Today, over 80 children from 30 countries are enrolled in a PRF-funded drug trial. Because of your support, the children are receiving the benefits of lonafarnib: stronger hearts and longer lives.

About PRF

Sammy-Basso- in USA

Your donation helps The Progeria Research Foundation treat children with Progeria today, and cure them in the future.

 

News

  • grants

October 2018: PRF Redesigns the Research Grant Program and is Soliciting Grant Proposals Worldwide

October 18th, 2018|0 Comments

Letters of Intent are due Oct. 30, 2018. For information on submitting an application and the complete PRF grant program, please visit the PRF Website here.
  • Newsletter-front-page

September 11th, 2018|0 Comments

Our 2018 Newsletter is HERE!  

Read about our remarkable progress over the past year, the latest developments in our clinical trial, our wonderful Chapters and Volunteers and so much more.
  • Eiger

May 15th, 2018|0 Comments

May 16, 2018: On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib.  

Collaboration marks first therapy submission for the treatment of Progeria. If approved, children may access drug by prescription instead of clinical trial. Click here for more details.
  • ZachHPFE

April 24, 2018: Global Study Published in JAMA Finds Treatment with Lonafarnib Extends Survival in Children with Progeria!

April 24th, 2018|0 Comments

A new study published in The Journal of the American Medical Association (JAMA) brings new hope and optimism to the Progeria community. Click here for more details.